Dummy Run of Quality Assurance Program in a Phase 3 Randomized Trial Investigating the Role of Internal Mammary Lymph Node Irradiation in Breast Cancer Patients: Korean Radiation Oncology Group 08-06 Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chung, Yoonsun | - |
dc.contributor.author | Kim, Jun Won | - |
dc.contributor.author | Shin, Kyung Hwan | - |
dc.contributor.author | Kim, Su Ssan | - |
dc.contributor.author | Ahn, Sung-Ja | - |
dc.contributor.author | Park, Won | - |
dc.contributor.author | Lee, Hyung-Sik | - |
dc.contributor.author | Kim, Dong Won | - |
dc.contributor.author | Lee, Kyu Chan | - |
dc.contributor.author | Suh, Hyun Suk | - |
dc.contributor.author | Kim, Jin Hee | - |
dc.contributor.author | Shin, Hyun Soo | - |
dc.contributor.author | Kim, Yong Bae | - |
dc.contributor.author | Suh, Chang-Ok | - |
dc.date.available | 2020-02-28T10:42:34Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2015-02-01 | - |
dc.identifier.issn | 0360-3016 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/10794 | - |
dc.description.abstract | Purpose: The Korean Radiation Oncology Group (KROG) 08-06 study protocol allowed radiation therapy (RT) technique to include or exclude breast cancer patients from receiving radiation therapy to the internal mammary lymph node (IMN). The purpose of this study was to assess dosimetric differences between the 2 groups and potential influence on clinical outcome by a dummy run procedure. Methods and Materials: All participating institutions were asked to produce RT plans without irradiation (Arm 1) and with irradiation to the IMN (Arm 2) for 1 breast-conservation treatment case (breast-conserving surgery [BCS]) and 1 mastectomy case (modified radical mastectomy [MRM]) whose computed tomography images were provided. We assessed interinstitutional variations in IMN delineation and evaluated the dose-volume histograms of the IMN and normal organs. A reference IMN was delineated by an expert panel group based on the study guidelines. Also, we analyzed the potential influence of actual dose variation observed in this study on patient survival. Results: Although physicians intended to exclude the IMN within the RT field, the data showed almost 59.0% of the prescribed dose was delivered to the IMN in Arm 1. However, the mean doses covering the IMN in Arm 1 and Arm 2 were significantly different for both cases (P<. 001). Due to the probability of overdose in Arm 1, the estimated gain in 7-year disease-free survival rate would be reduced from 10% to 7.9% for BCS cases and 7.1% for MRM cases. The radiation doses to the ipsilateral lung, heart, and coronary artery were lower in Arm 1 than in Arm 2. Conclusions: Although this dummy run study indicated that a substantial dose was delivered to the IMN, even in the nonirradiation group, the dose differences between the 2 groups were statistically significant. However, this dosimetric profile should be studied further with actual patient samples and be taken into consideration when analyzing clinical outcomes according to IMN irradiation. (C) 2015 Elsevier Inc. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | - |
dc.subject | EORTC RADIOTHERAPY GROUP | - |
dc.subject | STAGE-I | - |
dc.subject | ADJUVANT RADIOTHERAPY | - |
dc.subject | CHAIN | - |
dc.title | Dummy Run of Quality Assurance Program in a Phase 3 Randomized Trial Investigating the Role of Internal Mammary Lymph Node Irradiation in Breast Cancer Patients: Korean Radiation Oncology Group 08-06 Study | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000348045400024 | - |
dc.identifier.doi | 10.1016/j.ijrobp.2014.10.022 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, v.91, no.2, pp.419 - 426 | - |
dc.identifier.scopusid | 2-s2.0-84922447304 | - |
dc.citation.endPage | 426 | - |
dc.citation.startPage | 419 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | - |
dc.citation.volume | 91 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Lee, Kyu Chan | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | EORTC RADIOTHERAPY GROUP | - |
dc.subject.keywordPlus | STAGE-I | - |
dc.subject.keywordPlus | ADJUVANT RADIOTHERAPY | - |
dc.subject.keywordPlus | CHAIN | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.